Researcher
Gert De Meerleer
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Member
From1 Oct 2016 → Today
Projects
1 - 4 of 4
- Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE)From24 Sep 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Metastasis-directed therapy in castration-refractory prostate cancer: MEDCAREFrom1 Jan 2019 → 31 Dec 2022Funding: Foundations, funds and other with scientific goal
- Novel insights in the definition and treatment of high risk and oligometastatic prostate cancerFrom1 Oct 2018 → 18 Nov 2022Funding: FWO fellowships
- Traveling the prostate cancer timeline in chase of treatment paradigms Can we cure the incurable?From1 Aug 2017 → 1 Oct 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
61 - 70 of 117
- CHANGING PATTERNS AND PREDICTORS OF SALVAGE RADIATION THERAPY USE OVER TIME IN PATIENTS TREATED FOR POST-PROSTATECTOMY BIOCHEMICAL RECURRENCE: A TREND ANALYSIS OVER A 20-YEAR PERIOD FROM A MULTI-INSTITUTIONAL SERIES(2020)
Authors: Elio Mazzone, Nicola Fossati, Jeffrey Karnes, Stephen A Boorjian, Giovanni Motterle, Alberto Bossi, Tamizhanban Kumar, Nadia Di Muzio, Cesare Cozzarini, Barbara Noris Chiorda, et al.
Pages: E567 - E567 - ASSESSING THE IMPACT OF SALVAGE RADIATION THERAPY FIELD AFTER RADICAL PROSTATECTOMY: A LONG-TERM ANALYSIS FROM A LARGE MULTI-INSTITUTIONAL SERIES(2020)
Authors: Nicola Fossati, Jeffrey Karnes, Stephen A Boorjian, Giovanni Motterle, Alberto Bossi, Tamizhanban Kumar, Nadia Di Muzio, Cesare Cozzarini, Barbara Noris Chiorda, Elio Mazzone, et al.
Pages: E566 - E567 - Metastasectomy for visceral and skeletal oligorecurrent prostate cancer (vol 37, pg 1543, 2019)(2020)
Authors: Antonino Battaglia, Gaëtan Devos, Karel Decaestecker, Manuel Witters, Lisa Moris, Thomas Van den Broeck, Charlien Berghen, Wouter Everaerts, Maarten Albersen, Arman Tsaturyan, et al.
Pages: 1589 - 1589 - Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis(2020)
Authors: Gaëtan Devos, Wouter Everaerts, Maarten Albersen, Lisa Moris, Frank Claessens, Gert De Meerleer, Karin Haustermans, Hendrik Van Poppel, Steven Joniau
- dSalvage Radiotherapy for Prostate Cancer(2020)
Authors: Kato Rans, Charlien Berghen, Steven Joniau, Gert De Meerleer
Pages: 156 - 162 - A Trial-Based Cost-Utility Analysis of Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer(2020)
Authors: Steven Joniau, Gert De Meerleer
- Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study(2019)
Authors: Antonino Battaglia, Steven Joniau, Gert De Meerleer, Hendrik Van Poppel
Pages: 443 - 449 - Re: Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone McKay RR, Ye H, Xie W, et al J Clin Oncol 2019;37:923-31(2019)
Authors: Gaëtan Devos, Gert De Meerleer, Charlien Berghen, Steven Joniau
Pages: 537 - 538 - Progression-directed Therapy for Oligoprogression in Castration-refractory Prostate Cancer.(2019)
Authors: Charlien Berghen, Steven Joniau, Kenneth Poels, Wouter Everaerts, Karin Haustermans, Gaëtan Devos, Gert De Meerleer
Pages: 305 - 309 - Comparison of Peri-operative and Early Oncological Outcomes of Robot-Assisted vs. Open Salvage Lymph Node Dissection in Recurrent Prostate Cancer(2019)
Authors: Gaëtan Devos, Tim Muilwijk, Lisa Moris, Charlien Berghen, Gert De Meerleer, Maarten Albersen, Wouter Everaerts, Steven Joniau